CI

At a glance

ClinicalIndex Comparison Record
Phase 2Completed· 108 enrolled
Drug / intervention
Adjuvant Hypofractionated Radiationcombination
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02700386
NCT02700386Phase 2Completed
CompareCT.gov

Hypofractionated, Comprehensive Radiation Therapy for Node-Positive Breast Cancer

University of Colorado, Denver·interventional·Posted Mar 7, 2016·Updated Apr 30, 2026

In Brief

A Phase 2 clinical trial evaluating Adjuvant Hypofractionated Radiation for Breast Cancer. Completed, enrolled 108 participants across 3 sites.

Detailed Summary

The proposed study is being done to learn more about a particular dose of radiation treatment for breast cancer that is completed in a shorter amount of time than what has traditionally been used to treat breast cancer. Subjects are being asked to be in this research study because they have already had surgery for breast cancer and some cancer cells were found in their lymph nodes that drain the breast tissue.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsBreast Cancer
CountriesUnited States
Collaborators--

Timeline

Phase 2CompletedFinished
20162017201820192020202120222023202420252026
First PostedMar 7, 2016
Enrollment StartAug 11, 2016
Primary CompletionJun 13, 2024
TodayJul 2, 2026
Enrollment to primary: 7.8 yearsPosted 10.3 years ago

Interventions

Adjuvant Hypofractionated Radiationcombination

Hypofractionation is the delivery of radiotherapy in single daily doses greater than the 180-200 cGy. Hypofractionation, through use of larger doses per fraction and fewer total treatments, is a method of shortening overall treatment time in breast cancer therapy.